查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1406414

肿瘤资讯系统市场 - 全球产业规模、份额、趋势、机会和预测，按产品和服务、按应用、最终用户、地区和竞争细分，2018-2028

Oncology Information System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Services, By Application, By End User, By Region, and By Competition, 2018-2028
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球肿瘤资讯系统 (OIS) 市场正在经历显着的成长和转型，因为它在现代癌症护理中发挥越来越重要的作用。 OIS 是一款整合式软体解决方案，旨在管理肿瘤治疗和患者资料的复杂和多方面问题。该市场由几个关键因素推动，包括全球癌症负担不断增加、对更有效率和个人化癌症护理的需求、技术进步以及数据驱动决策在医疗保健领域日益重要。

OIS 系统提供广泛的功能，包括病患资料管理、治疗计划、日程安排、计费和报告。它们促进参与癌症治疗的医疗保健专业人员之间的无缝沟通和协作，从而实现更全面和协调的护理。此外，OIS 解决方案透过提供治疗计划验证、剂量验证和品质保证工具来提高癌症治疗的品质和安全性。

随着对改善癌症护理的需求不断增长，OIS 系统正在成为全球肿瘤诊所、医院和研究机构不可或缺的组成部分。他们支持医疗保健提供者提供基于证据和以患者为中心的护理，确保癌症患者接受最合适和有效的治疗。此外，OIS 平台透过支援患者资料和研究结果的管理，为癌症研究的进步做出了贡献。

市场概况
预测期 2024-2028
2022 年市场规模 30.3亿美元
2028 年市场规模 48.2亿美元
2023-2028 年CAGR 7.16%
成长最快的细分市场 专业服务
最大的市场 北美洲

该市场的特点是提供 OIS 解决方案的供应商多种多样，从成熟的医疗 IT 公司到专业的肿瘤软体提供者。这些公司竞相创新和增强其产品，引入人工智慧、机器学习和互通性等功能，以进一步提高癌症护理的准确性和效率。

成本和资源限制：

对于医疗机构来说，实施和维护先进的 OIS 可能需要大量资金，特别是预算有限的小型诊所和设施。平衡对尖端 OIS 功能的需求与预算限制是一个持续的挑战。

监理合规性：

医疗保健产业受到众多法规和合规要求的约束，包括与病患资料保护相关的法规和合规要求（例如美国的 HIPAA）。 OIS 提供者和医疗机构必须持续监控并适应不断变化的监管框架，这些框架可能很复杂，并且因地区而异。

新兴科技的整合：

OIS 必须跟上医疗保健技术的快速发展，包括人工智慧 (AI)、机器学习 (ML) 和基因组学。有效整合这些新兴技术，同时确保其临床有效性是一项挑战。此外，培训医疗保健专业人员使用这些先进工具也至关重要。

主要市场趋势

人工智慧和机器学习 (ML) 的整合：

人工智慧和机器学习透过分析大量患者资料集来识别趋势、预测结果和优化治疗计划，正在彻底改变肿瘤学资讯系统。这些技术帮助肿瘤科医师做出数据驱动的决策、加强病患照护并提高治疗效果。

远距医疗和远端监控：

COVID-19 大流行加速了肿瘤学中远距医疗和远端监测的采用。肿瘤学资讯系统现在配备了远距医疗功能，允许患者远端咨询肿瘤科医生。这种趋势确保了持续照护并最大限度地减少干扰，特别是对于接受长期治疗的患者。

个人化医疗和基因组数据整合：

基因组学的进步促进了肿瘤学个人化医疗的发展。肿瘤学资讯系统现在整合基因组资料，根据患者的基因谱量身订做治疗计画。这种方法可以提高治疗效果并最大限度地减少副作用。

基于云端的解决方案和资料可存取性：

基于云端的肿瘤学资讯系统提供安全储存、轻鬆存取以及医疗保健提供者之间的无缝资料共享。这种趋势促进了协作，降低了基础设施成本，并确保患者资料保持最新并可从任何地方存取。

患者参与和倖存者护理计划：

肿瘤学资讯系统越来越多地融入让患者积极参与护理的功能。倖存者照护计画对于帮助患者从治疗无缝过渡到后续照护变得越来越重要。这些计划也为患者提供了长期生存所需的资讯和资源。

细分市场洞察

产品与服务见解

到 2022 年，软体领域将在全球肿瘤资讯系统市场中占据主导地位。OIS 软体旨在高效收集、储存和管理对肿瘤治疗至关重要的大量患者资料。这包括患者病史、影像资料（例如 MRI 和 CT 扫描）、实验室结果和治疗计划。即时集中和存取这些资讯的能力可以增强临床决策。

OIS 软体提供先进的治疗计划工具，帮助肿瘤科医师为患者制定量身定制的治疗方案。这些系统使用先进的演算法来分析患者资料，帮助医疗保健提供者确定最合适的治疗和介入措施。治疗计划对于提高治疗效果和尽量减少副作用至关重要。

OIS 软体透过自动化管理任务、预约安排和资料输入来简化肿瘤学工作流程。这种效率使医疗保健专业人员能够更多地关注患者护理，而不是文书工作，最终提高生产力。

OIS 软体与其他医疗保健 IT 系统无缝集成，例如电子健康记录 (EHR) 和放射资讯系统 (RIS)，确保医疗机构内不同部门之间的资讯无缝流动。这种整合增强了护理协调并降低了错误风险。

OIS 软体提供强大的资料分析和报告功能。它允许医疗保健提供者追踪患者结果、评估治疗效果并进行研究。分析癌症治疗的趋势和模式可以导致治疗方案的不断改进。

应用洞察

到2022年，放射肿瘤学领域将在全球肿瘤学资讯系统市场中占据主导地位。放射治疗在癌症治疗中发挥关键作用，精准度至关重要。放射肿瘤学领域内的 OIS 系统经过专门设计，可确保准确的治疗计画。它们结合了 CT 扫描和 MRI 等先进的影像技术，可以精确瞄准肿瘤，同时最大限度地减少对周围健康组织的损害。这种精度水平对于放射治疗至关重要。

OIS 放射肿瘤学解决方案能够根据每位患者独特的解剖结构和状况制定高度个人化的治疗计划。他们考虑肿瘤大小、位置和对先前治疗的反应等因素，确保优化放射治疗以获得最大效果。

放射治疗依赖于计算最佳放射剂量来消灭癌细胞，同时保护健康组织。 OIS 软体在剂量计算和优化方面表现出色，可确保患者接受适量的辐射，从而以最小的副作用实现治疗目标。

放射肿瘤学部分包括即时治疗监测和实施的功能。 OIS 系统提供保障措施，以验证每次治疗期间是否准确提供规定的辐射剂量，让患者和临床医生安心。

在放射肿瘤学中，病人安全至关重要。该领域的 OIS 解决方案结合了安全检查和品质保证协议，以最大限度地减少治疗过程中出现错误的风险。它们还有助于遵守严格的监管标准和准则。

放射肿瘤学 OIS 软体与 PET/CT、MRI 和直线加速器等影像系统无缝整合。这种整合确保治疗计划基于最新的患者资料和成像结果，从而提高放射治疗的精确度。

区域洞察

到 2022 年，北美将主导全球肿瘤资讯系统市场。北美拥有高度发展、技术先进的医疗基础设施。该地区拥有一些世界领先的癌症治疗中心、研究机构和医疗机构。最先进的设备和熟练的劳动力使其成为采用 OIS 的沃土。

北美的癌症发生率相对较高。据美国癌症协会称，癌症是美国的主要原因之一。该地区癌症的流行促使医疗保健提供者投资 OIS 等先进解决方案，以有效管理患者资料、治疗计划和结果。

北美一直处于个人化医疗运动的最前沿，该运动根据个别患者的情况量身定制癌症治疗方法。 OIS 在收集和分析患者特定资料（包括遗传资讯和生物标记）以指导个人化治疗决策方面发挥着至关重要的作用。该地区对推动个人化医疗的承诺推动了对 OIS 解决方案的需求。

北美承担着全球肿瘤学研究和临床试验的很大一部分。该地区的学术机构、製药公司和医疗保健提供者积极参与临床研究。 OIS 促进了临床试验患者资料的管理，使其成为参与癌症研究的研究人员和机构不可或缺的工具。

北美拥有完善的监管机构，例如美国食品药物管理局 (FDA) 和加拿大卫生部，它们为 OIS 等医疗保健 IT 系统提供了明确的指导方针和法规。监管框架确保 OIS 解决方案的安全性和有效性，为医疗保健提供者註入信心并鼓励采用。

目录

第 1 章：服务概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

第 4 章：COVID-19 对全球肿瘤资讯系统市场的影响

第 5 章：客户之声

第 6 章：全球肿瘤资讯系统市场概述

第 7 章：全球肿瘤资讯系统市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依产品及服务（软体、专业服务）
    • 按应用（放射肿瘤学、肿瘤内科、肿瘤外科）
    • 按最终使用者（医院和肿瘤诊所、研究中心、其他）
    • 按地区（北美、欧洲、南美、中东和非洲、亚太地区）
  • 按公司划分 (2022)
  • 市场地图

第 8 章：北美肿瘤资讯系统市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品和服务
    • 按应用
    • 按最终用户
    • 按国家/地区

第 9 章：欧洲肿瘤资讯系统市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品和服务
    • 按应用
    • 按最终用户
    • 按国家/地区

第 10 章：南美洲肿瘤资讯系统市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品和服务
    • 按应用
    • 按最终用户
    • 按国家/地区

第 11 章：中东和非洲肿瘤资讯系统市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品和服务
    • 按应用
    • 按最终用户
    • 按国家/地区

第 12 章：亚太地区肿瘤资讯系统市场展望

  • 市场规模及预测
    • 按价值
  • 市场规模及预测
    • 按产品和服务
    • 按应用
    • 按最终用户
    • 按国家/地区

第 13 章：市场动态

  • 司机
  • 挑战

第 14 章：市场趋势与发展

第 15 章：公司简介

  • 医科达公司
    • Business Overview
    • Key Revenue and Financials
    • Recent Developments
    • Key Personnel
    • Key Product/Services Offered
  • 瓦里安医疗系统公司
    • Business Overview
    • Key Revenue and Financials
    • Recent Developments
    • Key Personnel
    • Key Product/Services Offered
  • 史诗系统公司
    • Business Overview
    • Key Revenue and Financials
    • Recent Developments
    • Key Personnel
    • Key Product/Services Offered
  • 飞利浦医疗保健
    • Business Overview
    • Key Revenue and Financials
    • Recent Developments
    • Key Personnel
    • Key Product/Services Offered
  • 塞纳公司
    • Business Overview
    • Key Revenue and Financials
    • Recent Developments
    • Key Personnel
    • Key Product/Services Offered
  • IBM公司
    • Business Overview
    • Key Revenue and Financials
    • Recent Developments
    • Key Personnel
    • Key Product/Services Offered
  • 西门子医疗公司
    • Business Overview
    • Key Revenue and Financials
    • Recent Developments
    • Key Personnel
    • Key Product/Services Offered
  • RaySearch 实验室AB
    • Business Overview
    • Key Revenue and Financials
    • Recent Developments
    • Key Personnel
    • Key Product/Services Offered
  • 皇家飞利浦公司
    • Business Overview
    • Key Revenue and Financials
    • Recent Developments
    • Key Personnel
    • Key Product/Services Offered
  • 麦克森公司
    • Business Overview
    • Key Revenue and Financials
    • Recent Developments
    • Key Personnel
    • Key Product/Services Offered

第 16 章：策略建议

第 17 章：关于我们与免责声明

简介目录
Product Code: 19583

The Global Oncology Information System (OIS) market is experiencing significant growth and transformation as it plays an increasingly crucial role in modern cancer care. OIS is an integrated software solution designed to manage the complex and multifaceted aspects of oncology treatment and patient data. This market is driven by several key factors, including the rising global cancer burden, the need for more efficient and personalized cancer care, advancements in technology, and the growing importance of data-driven decision-making in healthcare.

OIS systems offer a wide range of functionalities, including patient data management, treatment planning, scheduling, billing, and reporting. They facilitate seamless communication and collaboration among healthcare professionals involved in cancer treatment, leading to more comprehensive and coordinated care. Moreover, OIS solutions enhance the quality and safety of cancer treatments by providing tools for treatment plan validation, dose verification, and quality assurance.

As the demand for improved cancer care continues to rise, OIS systems are becoming integral components of oncology clinics, hospitals, and research institutions worldwide. They support healthcare providers in delivering evidence-based and patient-centered care, ensuring that cancer patients receive the most appropriate and effective treatments. Additionally, OIS platforms contribute to advancements in cancer research by enabling the management of patient data and research findings.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 3.03 Billion
Market Size 2028USD 4.82 Billion
CAGR 2023-20287.16%
Fastest Growing SegmentProfessional Service
Largest MarketNorth America

The market is characterized by a diverse array of vendors offering OIS solutions, ranging from established healthcare IT companies to specialized oncology software providers. These companies compete to innovate and enhance their offerings, introducing features like artificial intelligence, machine learning, and interoperability to further improve the accuracy and efficiency of cancer care.

Key Market Drivers

Rising Cancer Incidence Worldwide:

Cancer remains a major global health concern, with a steady increase in cancer cases. This escalating cancer incidence is a significant driver for the OIS market, as healthcare providers seek advanced solutions to efficiently manage patient data, treatment plans, and outcomes. OIS helps streamline oncology workflows and improve patient care, making it an indispensable tool in the fight against cancer.

Demand for Personalized Cancer Treatment:

Personalized medicine, including targeted therapies and precision oncology, is gaining prominence in cancer care. OIS plays a pivotal role in facilitating the collection and analysis of patient-specific data, such as genetic information and biomarkers. It enables oncologists to tailor treatment plans based on individual patient profiles, leading to more effective and less toxic treatments.

Technological Advancements in Healthcare IT:

The broader healthcare IT landscape is witnessing rapid technological advancements, including the integration of artificial intelligence (AI), machine learning (ML), and big data analytics. OIS providers are leveraging these technologies to enhance cancer diagnosis, treatment planning, and outcome prediction. AI-driven algorithms can assist oncologists in making data-driven decisions and identifying treatment options.

Increasing Emphasis on Data-Driven Medicine:

Data-driven decision-making is becoming increasingly essential in healthcare, particularly in oncology. OIS offers comprehensive tools for data management and analysis, allowing healthcare professionals to derive valuable insights from patient data. This data-centric approach is crucial for improving clinical outcomes, conducting research, and optimizing resource allocation.

Growing Oncology Research and Clinical Trials:

Oncology research and clinical trials are expanding to discover novel therapies and interventions. OIS plays a critical role in facilitating the management of patient data for clinical trials, helping researchers efficiently collect, analyze, and report clinical data. This drives the adoption of OIS solutions by research institutions, pharmaceutical companies, and healthcare providers participating in clinical trials.

Key Market Challenges

Data Security and Privacy Concerns:

In the oncology field, patient data is highly sensitive and must be protected. The challenge lies in ensuring robust data security and privacy compliance while making these systems accessible to healthcare providers. Striking the right balance between accessibility and security is an ongoing challenge.

Interoperability and Data Integration:

OIS often need to integrate with various healthcare systems, such as electronic health records (EHRs), radiology information systems (RIS), and laboratory information systems (LIS). Achieving seamless interoperability and data integration between these systems is a significant challenge, as it requires adherence to diverse data standards and protocols.

Cost and Resource Constraints:

Implementing and maintaining advanced OIS can be financially demanding for healthcare institutions, particularly smaller clinics and facilities with limited budgets. Balancing the need for cutting-edge OIS capabilities with budget constraints is an ongoing challenge.

Regulatory Compliance:

The healthcare sector is subject to numerous regulations and compliance requirements, including those related to patient data protection (e.g., HIPAA in the United States). OIS providers and healthcare institutions must continuously monitor and adapt to evolving regulatory frameworks, which can be complex and vary by region.

Integration of Emerging Technologies:

OIS must stay abreast of the rapid evolution of healthcare technology, including artificial intelligence (AI), machine learning (ML), and genomics. Integrating these emerging technologies effectively while ensuring their clinical validity poses a challenge. Additionally, training healthcare professionals to use these advanced tools is critical.

Key Market Trends

Integration of AI and Machine Learning (ML):

AI and ML are revolutionizing oncology information systems by analyzing vast patient data sets to identify trends, predict outcomes, and optimize treatment plans. These technologies assist oncologists in making data-driven decisions, enhancing patient care, and improving treatment effectiveness.

Telemedicine and Remote Monitoring:

The COVID-19 pandemic accelerated the adoption of telemedicine and remote monitoring in oncology. Oncology information systems are now equipped with telehealth features, allowing patients to consult with oncologists remotely. This trend ensures continuous care and minimizes disruptions, especially for patients undergoing long-term treatments.

Personalized Medicine and Genomic Data Integration:

Advancements in genomics have led to the growth of personalized medicine in oncology. Oncology information systems now integrate genomic data to tailor treatment plans based on a patient's genetic profile. This approach enhances treatment efficacy and minimizes adverse effects.

Cloud-Based Solutions and Data Accessibility:

Cloud-based oncology information systems provide secure storage, easy accessibility, and seamless data sharing among healthcare providers. This trend promotes collaboration, reduces infrastructure costs, and ensures that patient data remains up-to-date and accessible from anywhere.

Patient Engagement and Survivorship Care Plans:

Increasingly, oncology information systems are incorporating features to engage patients actively in their care. Survivorship care plans are gaining importance to help patients transition from treatment to follow-up care seamlessly. These plans also empower patients with information and resources for long-term survivorship.

Segmental Insights

Product & Services Insights

Software segment dominates in the global oncology information system market in 2022. OIS software is designed to efficiently collect, store, and manage vast amounts of patient data critical for oncology treatment. This includes patient medical histories, imaging data (such as MRIs and CT scans), laboratory results, and treatment plans. The ability to centralize and access this information in real-time enhances clinical decision-making.

OIS software offers sophisticated treatment planning tools that assist oncologists in creating tailored treatment regimens for patients. These systems use advanced algorithms to analyze patient data, helping healthcare providers determine the most appropriate therapies and interventions. Treatment planning is essential in improving treatment efficacy and minimizing side effects.

OIS software streamlines oncology workflows by automating administrative tasks, appointment scheduling, and data entry. This efficiency allows healthcare professionals to focus more on patient care and less on paperwork, ultimately enhancing productivity.

OIS software seamlessly integrates with other healthcare IT systems, such as electronic health records (EHRs) and radiology information systems (RIS), ensuring the seamless flow of information across different departments within a healthcare facility. This integration enhances care coordination and reduces the risk of errors.

OIS software provides robust data analytics and reporting capabilities. It allows healthcare providers to track patient outcomes, assess treatment effectiveness, and conduct research. Analyzing trends and patterns in cancer care can lead to continuous improvements in treatment protocols.

Application Insights

Radiation oncology segment dominates in the global oncology information system market in 2022. Radiation therapy plays a critical role in the treatment of cancer, and precision is paramount. OIS systems within the Radiation Oncology segment are specifically designed to ensure accurate treatment planning. They incorporate advanced imaging technologies, such as CT scans and MRI, to precisely target tumors while minimizing damage to surrounding healthy tissues. This level of precision is essential in radiation therapy.

OIS solutions for Radiation Oncology enable the development of highly personalized treatment plans tailored to each patient's unique anatomy and condition. They consider factors like tumor size, location, and response to previous treatments, ensuring that radiation therapy is optimized for maximum effectiveness.

Radiation therapy relies on calculating the optimal radiation dose to eradicate cancer cells while sparing healthy tissue. OIS software excels in dose calculation and optimization, ensuring that patients receive the right amount of radiation to achieve therapeutic goals with minimal side effects.

The Radiation Oncology segment includes features for real-time treatment monitoring and delivery. OIS systems offer safeguards to verify that the prescribed radiation dose is accurately delivered during each treatment session, providing peace of mind to both patients and clinicians.

Patient safety is paramount in radiation oncology. OIS solutions within this segment incorporate safety checks and quality assurance protocols to minimize the risk of errors during treatment. They also facilitate adherence to strict regulatory standards and guidelines.

Radiation Oncology OIS software seamlessly integrates with imaging systems such as PET/CT, MRI, and linear accelerators. This integration ensures that treatment plans are based on the most up-to-date patient data and imaging results, enhancing the precision of radiation therapy.

Regional Insights

North America dominates the Global Oncology Information System Market in 2022. North America boasts a highly developed and technologically advanced healthcare infrastructure. The region is home to some of the world's leading cancer treatment centers, research institutions, and healthcare facilities. The availability of state-of-the-art equipment and a skilled workforce has made it a fertile ground for the adoption of OIS.

North America has a relatively high incidence of cancer. According to the American Cancer Society, cancer is one of the leading causes of death in the United States. The prevalence of cancer in the region has prompted healthcare providers to invest in advanced solutions like OIS to efficiently manage patient data, treatment plans, and outcomes.

North America has been at the forefront of the personalized medicine movement, which tailors cancer treatments to individual patient profiles. OIS plays a crucial role in collecting and analyzing patient-specific data, including genetic information and biomarkers, to guide personalized treatment decisions. The region's commitment to advancing personalized medicine has driven the demand for OIS solutions.

North America hosts a significant portion of global oncology research and clinical trials. Academic institutions, pharmaceutical companies, and healthcare providers in the region actively participate in clinical research. OIS facilitates the management of patient data for clinical trials, making it an indispensable tool for researchers and institutions involved in cancer studies.

North America has well-established regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and Health Canada, which provide clear guidelines and regulations for healthcare IT systems like OIS. The regulatory framework ensures the safety and effectiveness of OIS solutions, instilling confidence in healthcare providers and encouraging adoption.

Key Market Players

Elekta AB

Varian Medical Systems, Inc.

Epic Systems Corporation

Philips Healthcare

Cerner Corporation

IBM Corporation

Siemens Healthineers

RaySearch Laboratories AB

Koninklijke Philips N.V.

McKesson Corporation

Report Scope:

In this report, the Global Oncology Information System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oncology Information System Market, By Product & Services:

  • Software
  • Professional Service

Oncology Information System Market, By Application:

  • Radiation Oncology
  • Medical Oncology
  • Surgical Oncology

Oncology Information System Market, By End User:

  • Hospital & Oncology Clinic
  • Research Center
  • Others

Oncology Information System Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Oncology Information System Market.

Available Customizations:

  • Global Oncology Information System Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Service Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Baseline Methodology
  • 2.2. Key Industry Partners
  • 2.3. Major Association and Secondary Sources
  • 2.4. Forecasting Methodology
  • 2.5. Data Triangulation & Validation
  • 2.6. Assumptions and Limitations

3. Executive Summary

4. Impact of COVID-19 on Global Oncology Information System Market

5. Voice of Customer

6. Global Oncology Information System Market Overview

7. Global Oncology Information System Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product & Services (Software, Professional Service)
    • 7.2.2. By Application (Radiation Oncology, Medical Oncology, Surgical Oncology)
    • 7.2.3. By End User (Hospital & Oncology Clinic, Research Center, Others)
    • 7.2.4. By Region (North America, Europe, South America, Middle East & Africa, Asia Pacific)
  • 7.3. By Company (2022)
  • 7.4. Market Map

8. North America Oncology Information System Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product & Services
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. United States Oncology Information System Market Outlook
        • 8.2.4.1.1. Market Size & Forecast
        • 8.2.4.1.1.1. By Value
        • 8.2.4.1.2. Market Share & Forecast
        • 8.2.4.1.2.1. By Product & Services
        • 8.2.4.1.2.2. By Application
        • 8.2.4.1.2.3. By End User
      • 8.2.4.2. Canada Oncology Information System Market Outlook
        • 8.2.4.2.1. Market Size & Forecast
        • 8.2.4.2.1.1. By Value
        • 8.2.4.2.2. Market Share & Forecast
        • 8.2.4.2.2.1. By Product & Services
        • 8.2.4.2.2.2. By Application
        • 8.2.4.2.2.3. By End User
      • 8.2.4.3. Mexico Oncology Information System Market Outlook
        • 8.2.4.3.1. Market Size & Forecast
        • 8.2.4.3.1.1. By Value
        • 8.2.4.3.2. Market Share & Forecast
        • 8.2.4.3.2.1. By Product & Services
        • 8.2.4.3.2.2. By Application
        • 8.2.4.3.2.3. By End User

9. Europe Oncology Information System Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product & Services
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
      • 9.2.4.1. Germany Oncology Information System Market Outlook
        • 9.2.4.1.1. Market Size & Forecast
        • 9.2.4.1.1.1. By Value
        • 9.2.4.1.2. Market Share & Forecast
        • 9.2.4.1.2.1. By Product & Services
        • 9.2.4.1.2.2. By Application
        • 9.2.4.1.2.3. By End User
      • 9.2.4.2. France Oncology Information System Market Outlook
        • 9.2.4.2.1. Market Size & Forecast
        • 9.2.4.2.1.1. By Value
        • 9.2.4.2.2. Market Share & Forecast
        • 9.2.4.2.2.1. By Product & Services
        • 9.2.4.2.2.2. By Application
        • 9.2.4.2.2.3. By End User
      • 9.2.4.3. United Kingdom Oncology Information System Market Outlook
        • 9.2.4.3.1. Market Size & Forecast
        • 9.2.4.3.1.1. By Value
        • 9.2.4.3.2. Market Share & Forecast
        • 9.2.4.3.2.1. By Product & Services
        • 9.2.4.3.2.2. By Application
        • 9.2.4.3.2.3. By End User
      • 9.2.4.4. Italy Oncology Information System Market Outlook
        • 9.2.4.4.1. Market Size & Forecast
        • 9.2.4.4.1.1. By Value
        • 9.2.4.4.2. Market Share & Forecast
        • 9.2.4.4.2.1. By Product & Services
        • 9.2.4.4.2.2. By Application
        • 9.2.4.4.2.3. By End User
      • 9.2.4.5. Spain Oncology Information System Market Outlook
        • 9.2.4.5.1. Market Size & Forecast
        • 9.2.4.5.1.1. By Value
        • 9.2.4.5.2. Market Share & Forecast
        • 9.2.4.5.2.1. By Product & Services
        • 9.2.4.5.2.2. By Application
        • 9.2.4.5.2.3. By End User

10. South America Oncology Information System Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product & Services
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
      • 10.2.4.1. Brazil Oncology Information System Market Outlook
        • 10.2.4.1.1. Market Size & Forecast
        • 10.2.4.1.1.1. By Value
        • 10.2.4.1.2. Market Share & Forecast
        • 10.2.4.1.2.1. By Product & Services
        • 10.2.4.1.2.2. By Application
        • 10.2.4.1.2.3. By End User
      • 10.2.4.2. Colombia Oncology Information System Market Outlook
        • 10.2.4.2.1. Market Size & Forecast
        • 10.2.4.2.1.1. By Value
        • 10.2.4.2.2. Market Share & Forecast
        • 10.2.4.2.2.1. By Product & Services
        • 10.2.4.2.2.2. By Application
        • 10.2.4.2.2.3. By End User
      • 10.2.4.3. Argentina Oncology Information System Market Outlook
        • 10.2.4.3.1. Market Size & Forecast
        • 10.2.4.3.1.1. By Value
        • 10.2.4.3.2. Market Share & Forecast
        • 10.2.4.3.2.1. By Product & Services
        • 10.2.4.3.2.2. By Application
        • 10.2.4.3.2.3. By End User

11. Middle East & Africa Oncology Information System Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product & Services
    • 11.2.2. By Application
    • 11.2.3. By End User
    • 11.2.4. By Country
      • 11.2.4.1. Saudi Arabia Oncology Information System Market Outlook
        • 11.2.4.1.1. Market Size & Forecast
        • 11.2.4.1.1.1. By Value
        • 11.2.4.1.2. Market Share & Forecast
        • 11.2.4.1.2.1. By Product & Services
        • 11.2.4.1.2.2. By Application
        • 11.2.4.1.2.3. By End User
      • 11.2.4.2. UAE Oncology Information System Market Outlook
        • 11.2.4.2.1. Market Size & Forecast
        • 11.2.4.2.1.1. By Value
        • 11.2.4.2.2. Market Share & Forecast
        • 11.2.4.2.2.1. By Product & Services
        • 11.2.4.2.2.2. By Application
        • 11.2.4.2.2.3. By End User
      • 11.2.4.3. South Africa Oncology Information System Market Outlook
        • 11.2.4.3.1. Market Size & Forecast
        • 11.2.4.3.1.1. By Value
        • 11.2.4.3.2. Market Share & Forecast
        • 11.2.4.3.2.1. By Product & Services
        • 11.2.4.3.2.2. By Application
        • 11.2.4.3.2.3. By End User

12. Asia Pacific Oncology Information System Market Outlook

  • 12.1. Market Size & Forecast
    • 12.1.1. By Value
  • 12.2. Market Size & Forecast
    • 12.2.1. By Product & Services
    • 12.2.2. By Application
    • 12.2.3. By End User
    • 12.2.4. By Country
      • 12.2.4.1. China Oncology Information System Market Outlook
        • 12.2.4.1.1. Market Size & Forecast
        • 12.2.4.1.1.1. By Value
        • 12.2.4.1.2. Market Share & Forecast
        • 12.2.4.1.2.1. By Product & Services
        • 12.2.4.1.2.2. By Application
        • 12.2.4.1.2.3. By End User
      • 12.2.4.2. India Oncology Information System Market Outlook
        • 12.2.4.2.1. Market Size & Forecast
        • 12.2.4.2.1.1. By Value
        • 12.2.4.2.2. Market Share & Forecast
        • 12.2.4.2.2.1. By Product & Services
        • 12.2.4.2.2.2. By Application
        • 12.2.4.2.2.3. By End User
      • 12.2.4.3. Japan Oncology Information System Market Outlook
        • 12.2.4.3.1. Market Size & Forecast
        • 12.2.4.3.1.1. By Value
        • 12.2.4.3.2. Market Share & Forecast
        • 12.2.4.3.2.1. By Product & Services
        • 12.2.4.3.2.2. By Application
        • 12.2.4.3.2.3. By End User
      • 12.2.4.4. South Korea Oncology Information System Market Outlook
        • 12.2.4.4.1. Market Size & Forecast
        • 12.2.4.4.1.1. By Value
        • 12.2.4.4.2. Market Share & Forecast
        • 12.2.4.4.2.1. By Product & Services
        • 12.2.4.4.2.2. By Application
        • 12.2.4.4.2.3. By End User
      • 12.2.4.5. Australia Oncology Information System Market Outlook
        • 12.2.4.5.1. Market Size & Forecast
        • 12.2.4.5.1.1. By Value
        • 12.2.4.5.2. Market Share & Forecast
        • 12.2.4.5.2.1. By Product & Services
        • 12.2.4.5.2.2. By Application
        • 12.2.4.5.2.3. By End User

13. Market Dynamics

  • 13.1. Drivers
  • 13.2. Challenges

14. Market Trends and Developments

15. Company Profiles

  • 15.1. Elekta AB
    • 15.1.1. Business Overview
    • 15.1.2. Key Revenue and Financials
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. Key Product/Services Offered
  • 15.2. Varian Medical Systems, Inc.
    • 15.2.1. Business Overview
    • 15.2.2. Key Revenue and Financials
    • 15.2.3. Recent Developments
    • 15.2.4. Key Personnel
    • 15.2.5. Key Product/Services Offered
  • 15.3. Epic Systems Corporation
    • 15.3.1. Business Overview
    • 15.3.2. Key Revenue and Financials
    • 15.3.3. Recent Developments
    • 15.3.4. Key Personnel
    • 15.3.5. Key Product/Services Offered
  • 15.4. Philips Healthcare
    • 15.4.1. Business Overview
    • 15.4.2. Key Revenue and Financials
    • 15.4.3. Recent Developments
    • 15.4.4. Key Personnel
    • 15.4.5. Key Product/Services Offered
  • 15.5. Cerner Corporation
    • 15.5.1. Business Overview
    • 15.5.2. Key Revenue and Financials
    • 15.5.3. Recent Developments
    • 15.5.4. Key Personnel
    • 15.5.5. Key Product/Services Offered
  • 15.6. IBM Corporation
    • 15.6.1. Business Overview
    • 15.6.2. Key Revenue and Financials
    • 15.6.3. Recent Developments
    • 15.6.4. Key Personnel
    • 15.6.5. Key Product/Services Offered
  • 15.7. Siemens Healthineers
    • 15.7.1. Business Overview
    • 15.7.2. Key Revenue and Financials
    • 15.7.3. Recent Developments
    • 15.7.4. Key Personnel
    • 15.7.5. Key Product/Services Offered
  • 15.8. RaySearch Laboratories AB
    • 15.8.1. Business Overview
    • 15.8.2. Key Revenue and Financials
    • 15.8.3. Recent Developments
    • 15.8.4. Key Personnel
    • 15.8.5. Key Product/Services Offered
  • 15.9. Koninklijke Philips N.V.
    • 15.9.1. Business Overview
    • 15.9.2. Key Revenue and Financials
    • 15.9.3. Recent Developments
    • 15.9.4. Key Personnel
    • 15.9.5. Key Product/Services Offered
  • 15.10. McKesson Corporation
    • 15.10.1. Business Overview
    • 15.10.2. Key Revenue and Financials
    • 15.10.3. Recent Developments
    • 15.10.4. Key Personnel
    • 15.10.5. Key Product/Services Offered

16. Strategic Recommendations

17. About Us & Disclaimer